Abbas UL - Search Results

1

Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.

Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, Abbas UL. Glaubius RL, et al. Among authors: abbas ul. Clin Infect Dis. 2016 Aug 15;63(4):539-47. doi: 10.1093/cid/ciw321. Epub 2016 May 18. Clin Infect Dis. 2016. PMID: 27193745 Free PMC article.

2

Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.

Abbas UL, Glaubius R, Mubayi A, Hood G, Mellors JW. Abbas UL, et al. J Infect Dis. 2013 Jul 15;208(2):224-34. doi: 10.1093/infdis/jit150. Epub 2013 Apr 9. J Infect Dis. 2013. PMID: 23570850 Free PMC article.

3

Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.

van de Vijver DA, Nichols BE, Abbas UL, Boucher CA, Cambiano V, Eaton JW, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff KC, Hallett TB. van de Vijver DA, et al. Among authors: abbas ul. AIDS. 2013 Nov 28;27(18):2943-51. doi: 10.1097/01.aids.0000433237.63560.20. AIDS. 2013. PMID: 23939237

4

Antiretroviral treatment, preexposure prophylaxis, and drug resistance in sub-Saharan Africa: a consensus among mathematical models.

Abbas UL, Glaubius R, Hood G, Mellors JW. Abbas UL, et al. J Infect Dis. 2014 Jan 1;209(1):164-6. doi: 10.1093/infdis/jit545. Epub 2013 Oct 16. J Infect Dis. 2014. PMID: 24133186 No abstract available.

5

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.

Glaubius RL, Parikh UM, Hood G, Penrose KJ, Bendavid E, Mellors JW, Abbas UL. Glaubius RL, et al. Among authors: abbas ul. Open Forum Infect Dis. 2016 Jun 16;3(3):ofw125. doi: 10.1093/ofid/ofw125. eCollection 2016 Sep. Open Forum Infect Dis. 2016. PMID: 27703992 Free PMC article.

6

Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.

Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL. Glaubius R, et al. Among authors: abbas ul. J Int AIDS Soc. 2019 May;22(5):e25282. doi: 10.1002/jia2.25282. J Int AIDS Soc. 2019. PMID: 31074936 Free PMC article.

7

Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study.

Abbas UL, Glaubius RL, Ding Y, Hood G. Abbas UL, et al. PLoS One. 2019 Jul 3;14(7):e0218649. doi: 10.1371/journal.pone.0218649. eCollection 2019. PLoS One. 2019. PMID: 31269034 Free PMC article.

8

Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Abbas UL, Mellors JW. Abbas UL, et al. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13377-8. doi: 10.1073/pnas.212518999. Epub 2002 Oct 7. Proc Natl Acad Sci U S A. 2002. PMID: 12370421 Free PMC article. Review. No abstract available.

9

Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.

Abbas UL, Anderson RM, Mellors JW. Abbas UL, et al. J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):632-41. doi: 10.1097/01.qai.0000194234.31078.bf. J Acquir Immune Defic Syndr. 2006. PMID: 16652038

10

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings.

Abbas UL, Anderson RM, Mellors JW. Abbas UL, et al. PLoS One. 2007 Sep 19;2(9):e875. doi: 10.1371/journal.pone.0000875. PLoS One. 2007. PMID: 17878928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters